Who owns the GLENMARK THERAPEUTICS trademark?

The GLENMARK THERAPEUTICS trademark is owned by Glenmark Therapeutics Inc., USA.

What class is the GLENMARK THERAPEUTICS trademark registered in?

The GLENMARK THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for GLENMARK THERAPEUTICS?

The USPTO serial number for GLENMARK THERAPEUTICS is 97976501.

What is the registration number for GLENMARK THERAPEUTICS?

GLENMARK THERAPEUTICS is registered under USPTO registration number 7317749.

GLE

USPTO Trademark Record

REGISTERED

GLENMARK THERAPEUTICS

SN 97976501·Reg 7317749·Filed Apr 04, 2022

Owner Glenmark Therapeutics Inc., USA

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

GLENMARK THERAPEUTICS (Serial No. 97976501), Registration No. 7317749, is a registered US trademark filed on Apr 04, 2022 by Glenmark Therapeutics Inc., USA. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: February 27, 2030

Mark Intelligence

GLENMARK THERAPEUTICS (Reg. #7317749) is a registered US trademark that has been protecting its owner, Glenmark Therapeutics Inc., USA, since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 04, 2022

SERIAL

97976501

REG#

7317749

REGISTERED

Feb 27, 2024

Owner

Applicant

Glenmark Therapeutics Inc., USA

Entity

Corporation

State

Address

750 Corporate Dr., Suite 201-S, Mahwah, NJ, 07430

Country

Attorney

NameMaxim A. Voltchenko

Law firm

Maxim A. Voltchenko KAPLAN BREYER SCHWARZ, LLP

Docket

4007-106TMUS

Address

317 George Street, Ste 320, New Brunswick, NJ 08901, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateApr 04, 2022

Serial Number97976501

Registration No.7317749

Registration DateFeb 27, 2024

Status DateFeb 27, 2024

Published for OppositionSep 20, 2022

Mark TypeStandard characters

Attorney Docket4007-106TMUS

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jul 06, 2022

First use in commerce: Aug 01, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

41 events

TEAS CHANGE OF OWNER ADDRESS RECEIVED

May 19, 2025

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

May 19, 2025

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

May 19, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

May 19, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 19, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Feb 27, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 27, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 25, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 24, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

SU - NON-FINAL ACTION - WRITTEN

Dec 15, 2023

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Dec 15, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 15, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

DIVISIONAL PROCESSING COMPLETE

Sep 18, 2023

DIVISIONAL PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 31, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 26, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS/EMAIL CORRESPONDENCE ENTERED

May 04, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS REQUEST TO DIVIDE RECEIVED

May 03, 2023

TEAS REQUEST TO DIVIDE RECEIVED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 03, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 03, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

DIVISIONAL REQUEST RECEIVED

May 03, 2023

DIVISIONAL REQUEST RECEIVED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 27, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION E-MAILED

Mar 27, 2023

NON-FINAL ACTION E-MAILED

SU - NON-FINAL ACTION - WRITTEN

Mar 27, 2023

SU - NON-FINAL ACTION - WRITTEN

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 16, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Feb 16, 2023

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Jan 18, 2023

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Jan 18, 2023

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 15, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Sep 20, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 20, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 31, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 17, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 22, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 22, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 22, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

May 12, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 12, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 12, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

May 11, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 08, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 07, 2022

NEW APPLICATION ENTERED

GLENMARK THERAPEUTICS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Glenmark Therapeutics Inc., USA

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Maxim A. Voltchenko

Resources

Company